Normalized claim
Simulation speedup: 2 x increase
2x faster molecular simulation times on modern hardware
Ryvu Therapeutics is an oncology biotech company that relies on computational methods such as molecular docking, molecular dynamics, protein structure prediction, and physics-based free energy perturbation calculations to prioritize chemical compounds for drug discovery. The company needed to overcome an on-premises compute bottleneck that pushed simulation turnarounds from hours into weeks and slowed down medicinal chemistry synthesis cycles. It built an automated in silico evaluation pipeline on Google Cloud using Google Batch, Compute Engine GPUs, Cloud Storage, and Nextflow orchestration, with Gemini also mentioned among products in the source.
Reported outcomes
2x
simulation speedupTime & speed
Strategic outcomes
Catalog median for time & speed deployments: +60% across 143 reported metrics. Compare benchmarks →
Normalized claim
Simulation speedup: 2 x increase
2x faster molecular simulation times on modern hardware
Normalized claim
Manual data preparation time saved per week: 5-10 hours per week decrease
5-10 hours saved per week on manual data preparation
Normalized claim
False positives reduced: 50% decrease
reducing false positives by 50%
It built an automated in silico evaluation pipeline on Google Cloud using Google Batch, Compute Engine GPUs, Cloud Storage, and Nextflow orchestration, with Gemini also mentioned among products in the source
Primary read
Showing 2 of 2
AI-generated summary. Verify important details with the linked sources before relying on this case.
Was this useful?
Community
No published comments yet.